Identification of Y118 Amino Acid Residue in Candida albicans Sterol 14.ALPHA.-Demethylase Associated with the Enzyme Activity and Selective Antifungal Activity of Azole Analogues
Authors:
- 1 January 2007
- journal article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 30 (7) , 1246-1253
Abstract
Our previous publication established a model to predict that the phenyl group of the C-3 side chain of azole antifungal compounds interacts with the phenol group of Tyr118 through the formation of pi-pi face-to-edge interaction. To verify this prediction, wild type and three site-directed mutants of the Y118 residue of Candida albicans sterol 14alpha-demethylase P450 (CACYP51) were constructed and heterologously expressed in Saccharomyces cerevisiae with deletion of the CYP51 gene. With the strains obtained and microsome enzymes separated, cell susceptibility and CACYP51 activity were examined with the 5 novel azole compounds based on the molecular modeling in comparison with fluconazole. After alteration of Y118 with Y118A, Y118F, and Y118T by a single base substitution, the expression levels of CACYP51 protein were not affected. However, these mutations markedly decreased its catalytic activity respectively; the mutation changes also decreased azole susceptibility, indicating the structural importance of the Y118 residue in maintaining CACYP51 activity and in determining azole susceptibility. In addition, our synthetic compounds with the phenyl group side chain attached to C3 produced higher susceptibility against S. cerevisiae with expression of CACYP51 and exhibited more potent inhibitory effects on CACYP51 activity in comparison with fluconazole, suggesting that the phenyl group of C3 side chain substitutes is also important for selective binding to target enzymes.Keywords
This publication has 31 references indexed in Scilit:
- Candida albicans Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2003
- Genetic Basis for Differential Activities of Fluconazole and Voriconazole against Candida kruseiAntimicrobial Agents and Chemotherapy, 2003
- Conservation and cloning of CYP51: a sterol 14α-demethylase from Mycobacterium smegmatisBiochemical and Biophysical Research Communications, 2003
- Structure-Based de Novo Design, Synthesis, and Biological Evaluation of Non-Azole Inhibitors Specific for Lanosterol 14α-Demethylase of FungiJournal of Medicinal Chemistry, 2003
- Molecular basis of resistance to azole antifungalsTrends in Molecular Medicine, 2002
- Strong Antifungal Activity of SS750, a New Triazole Derivative, Is Based on Its Selective Binding Affinity to Cytochrome P450 of FungiAntimicrobial Agents and Chemotherapy, 2002
- The R467K Amino Acid Substitution in Candida albicans Sterol 14α-Demethylase Causes Drug Resistance through Reduced AffinityAntimicrobial Agents and Chemotherapy, 2000
- Y132H substitution in Candida albicans sterol 14α-demethylase confers fluconazole resistance by preventing binding to haemFEMS Microbiology Letters, 1999
- Molecular Modelling of Lanosterol 14α-Demethylase (CYPSl) fromSaccharomyces Cerevisiaevia Homology with CYP102, a Unique Bacterial Cytochrome P450 Isoform: Quantitative Structure-Activity Relationships (QSARs) within two Related Series of Antifungal Azole DerivativesJournal of Enzyme Inhibition, 1999
- The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced AffinityJournal of Biological Chemistry, 1997